title: Reversal of target-specific oral anticoagulants.
abstract: The target-specific oral anticoagulants represent the first new oral anti-thrombotic therapy in over 50 years and have the potential to make therapy easier and hence more accessible to many patients. Like any new therapy, the potential benefits must be weighed against the potential challenges and one of the most concerning aspects of the new target-specific oral anticoagulants is the lack of a proven method to reverse their effect. Unlike the vitamin K antagonist, i.e. warfarin, there is no specific antidote for these medications. This paper will review the limited data on the use of non-specific therapies to reverse anticoagulation for the new agents. We hope to prepare clinicians who are faced with a patient who has serious bleeding or needs emergent surgery while taking dabigatran, rivaroxaban or apixaban.
authors: Hospital Medicine, Hurley Medical Center, One Hurley Plaza, Flint, MI 48503, USA. skaatz1@hurleymc.com
authors: Scott
authors: S
authors: Kaatz
authors: Mark
authors: M
authors: Crowther
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D016503:Drug Delivery Systems; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D004502:Education, Medical, Continuing; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans
chemical_list: D000925:Anticoagulants
references: Anesthesiology. 2012 Jan;116(1):94-102
references: 22042412
references: Thromb Haemost. 2013 Apr;109(4):596-605
references: 23389759
references: Int J Lab Hematol. 2013 Apr;35(2):222-4
references: 23020832
references: Thromb Haemost. 2011 Sep;106(3):429-38
references: 21800002
references: Clin Pharmacokinet. 2010 Apr;49(4):259-68
references: 20214409
references: PLoS One. 2013 Nov 11;8(11):e78696
references: 24244342
references: Am J Health Syst Pharm. 2012 Sep 1;69(17):1473-84
references: 22899742
references: N Engl J Med. 2010 Nov 4;363(19):1791-800
references: 21047223
references: J Thromb Haemost. 2012 Sep;10(9):1830-40
references: 22817470
references: J Thromb Haemost. 2009 Jul;7 Suppl 1:107-10
references: 19630780
references: J Thromb Haemost. 2012 Sep;10(9):1841-8
references: 22812619
references: Blood. 2010 Aug 5;116(5):693-701
references: 20385794
references: Stroke. 2011 Dec;42(12):3594-9
references: 21998060
references: Thromb Haemost. 2012 Aug;108(2):217-24
references: 22627883
references: Circulation. 2011 Oct 4;124(14):1573-9
references: 21900088
references: Chest. 2012 Feb;141(2 Suppl):e152S-e184S
references: 22315259
references: Am J Hematol. 2012 May;87 Suppl 1:S141-5
references: 22473649